Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03389854 · ClinicalTrials.gov registry record · NA
Efficacy of Penile Traction Therapy Using a Novel Device
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 110
- Enrollment target
NCT03389854: Completed NA study, sponsored by Mayo Clinic.
NCT03389854 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 110 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03389854, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
Study Summary
This clinical trial is designed to assess the safety, dosing, and preliminary efficacy of a novel penile traction device on correcting deformities relating to Peyronie's disease, a condition which results in penile curvature and length loss. The trial is designed as a randomized, placebo-controlled study with men randomized to receiving no therapy or penile traction therapy 30 minutes once, twice, or three times daily. The study will occur over a 3 month period, after which an open label phase for 3 months will be conducted. Final assessments for adverse effects will also be assessed at 9 months.
Interventions
- DEVICE RestoreX PTT - randomized and open label
- DEVICE RestoreX PTT - open label phase only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2017-10-02 |
| Est. Completion | 2019-06-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03389854
The ClinicalTrials.gov registry entry for NCT03389854 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which RestoreX PTT - randomized and open label is the first listed.
NCT03389854 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03389854 about?
NCT03389854 is a clinical study titled "Efficacy of Penile Traction Therapy Using a Novel Device". This clinical trial is designed to assess the safety, dosing, and preliminary efficacy of a novel penile traction device on correcting deformities relating to Peyronie's disease, a condition which results in penile curvature and length loss. The trial is designed as a randomized, placebo-controlled ...
What is the current status of trial NCT03389854?
This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2017-10-02. Estimated completion is 2019-06-04.
What interventions are being tested in trial NCT03389854?
The interventions under investigation include: RestoreX PTT - randomized and open label (DEVICE), RestoreX PTT - open label phase only (DEVICE).
Who is sponsoring clinical trial NCT03389854?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.